Kedrion Biopharma
Cecilia Conz currently serves as a Clinical Trial Manager at Kedrion Biopharma, a position held since November 2023. Prior to this, Cecilia worked at Dompé from September 2021 to November 2023 as a Site Engagement and Clinical Trial Manager, after serving in a similar role as Site Engagement & Clinical Trial Manager Consultant at JSB Solutions. Cecilia's background includes extensive experience as a Senior Clinical Research Associate at Bayer, PRA Health Sciences, and Quintiles, as well as roles at Medidata and Medineos. Educational qualifications include a II level master in Pre-clinical and Clinical R&D from Università di Milano Bicocca and a Master’s degree in Industrial Biotechnology from Università degli Studi di Milano-Bicocca.
This person is not in any teams
Kedrion Biopharma
19 followers
Kedrion Biopharma is a biopharmaceutical company that collects and fractionates blood plasma to produce and distribute worldwide plasma-derived therapies for use in treating and preventing rare and serious diseases and conditions. In 2022, Kedrion joined forces with BPL (Bio Products Laboratory). Based in the United Kingdom, BPL has over 60 years of experience in the supply of high-quality plasma-derived medicines to treat rare diseases. Kedrion distributes its products in over 100 countries around the world. We have plants in Italy, Hungary, UK and North America, and plasma collection centers in the US and in the Czech Republic. With these figures we are the world’s 5th top player in the field of plasma-derived products. Our goal is to build a diverse and professional workforce, providing job opportunities for talented external candidates as well as internal employees who aim to grow with us. Because our work includes so many interests and skills – from Research to Sales; Plasma Collection to Production – there are abundant possibilities for learning and growth. Kedrion builds bridges: from donors to patients, from plasma to therapies, from challenge to hope.